Bristol-Myers Squibb Target of Unusually High Options Trading (BMY)
Shares of Bristol-Myers Squibb (NYSE:BMY) was the recipient of unusually large options trading activity on Friday. Traders acquired 83,246 call options on the company, AnalystRatingsNetwork reports. This is an increase of approximately 297% compared to the average volume of 20,970 call options.
BMY has been the subject of a number of recent research reports. Analysts at Barclays upgraded shares of Bristol-Myers Squibb from an “equal weight” rating to an “overweight” rating in a research note to investors on Friday. They now have a $65.00 price target on the stock, up previously from $52.00. Separately, analysts at TheStreet reiterated a “buy” rating on shares of Bristol-Myers Squibb in a research note to investors on Thursday. Finally, analysts at Jefferies Group raised their price target on shares of Bristol-Myers Squibb from $48.00 to $50.00 in a research note to investors on Thursday. They now have a “hold” rating on the stock. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $52.86.
Shares of Bristol-Myers Squibb (NYSE:BMY) traded up 2.09% on Friday, hitting $56.18. 14,494,735 shares of the company’s stock traded hands. Bristol-Myers Squibb has a 52-week low of $33.95 and a 52-week high of $55.09. The stock has a 50-day moving average of $52.22 and a 200-day moving average of $47.60. The company has a market cap of $92.503 billion and a price-to-earnings ratio of 33.03.
Bristol-Myers Squibb (NYSE:BMY) last released its earnings data on Wednesday, October 23rd. The company reported $0.46 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.44 by $0.02. The company had revenue of $4.07 billion for the quarter, compared to the consensus estimate of $4.02 billion. During the same quarter in the previous year, the company posted $0.41 earnings per share. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. Analysts expect that Bristol-Myers Squibb will post $1.75 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Monday, February 3rd. Shareholders of record on Friday, January 3rd will be given a dividend of 0.36 per share. This represents a $1.44 dividend on an annualized basis and a yield of 2.56%. The ex-dividend date of this dividend is Tuesday, December 31st. This is a positive change from Bristol-Myers Squibb’s previous quarterly dividend of $0.35.
Bristol-Myers Squibb Company (NYSE:BMY) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.